We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIER
1726
DELISTED
TIER REIT, Inc.
TIER
$1.73M ﹤0.01%
83,932
+26,506
+46% +$594K
APTI
1727
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$1.73M ﹤0.01%
45,611
+15,058
+49% +$509K
HURN icon
1728
Huron Consulting
HURN
$2.38B
$1.73M ﹤0.01%
33,707
+9,470
+39% +$482K
CNNE icon
1729
Cannae Holdings
CNNE
$649M
$1.73M ﹤0.01%
100,779
+30,110
+43% +$542K
KRNY icon
1730
Kearny Financial
KRNY
$604M
$1.72M ﹤0.01%
134,368
+32,751
+32% +$426K
EXTN
1731
DELISTED
Exterran Corporation
EXTN
$1.72M ﹤0.01%
97,265
+15,817
+19% +$355K
PTLA
1732
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.72M ﹤0.01%
87,962
+28,632
+48% +$589K
NPK icon
1733
National Presto Industries
NPK
$993M
$1.72M ﹤0.01%
14,680
+1,700
+13% +$213K
RGS icon
1734
Regis Corp
RGS
$70M
$1.72M ﹤0.01%
5,063
+836
+20% +$299K
ACLS icon
1735
Axcelis
ACLS
$4.23B
$1.71M ﹤0.01%
96,297
+16,640
+21% +$296K
AERI
1736
DELISTED
Aerie Pharmaceuticals
AERI
$1.71M ﹤0.01%
47,468
+15,074
+47% +$707K
I
1737
DELISTED
INTELSAT S. A.
I
$1.71M ﹤0.01%
80,131
+35,639
+80% +$963K
RGP icon
1738
Resources Connection
RGP
$146M
$1.71M ﹤0.01%
120,532
+15,482
+15% +$251K
ICFI icon
1739
ICF International
ICFI
$1.54B
$1.71M ﹤0.01%
26,358
+7,717
+41% +$541K
GTN icon
1740
Gray Television
GTN
$444M
$1.7M ﹤0.01%
115,564
+34,434
+42% +$598K
ROKU icon
1741
Roku
ROKU
$22.3B
$1.7M ﹤0.01%
55,586
+17,044
+44% +$803K
UIS icon
1742
Unisys
UIS
$210M
$1.7M ﹤0.01%
146,429
+26,062
+22% +$410K
ETD icon
1743
Ethan Allen Interiors
ETD
$601M
$1.7M ﹤0.01%
96,652
+11,908
+14% +$234K
MNR
1744
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.7M ﹤0.01%
137,130
+47,277
+53% +$688K
CADE
1745
DELISTED
Cadence Bancorporation
CADE
$1.7M ﹤0.01%
101,191
+34,184
+51% +$725K
TGI
1746
DELISTED
Triumph Group
TGI
$1.7M ﹤0.01%
147,504
+25,502
+21% +$443K
AMRX icon
1747
Amneal Pharmaceuticals
AMRX
$5.75B
$1.7M ﹤0.01%
125,310
+37,713
+43% +$680K
UI icon
1748
Ubiquiti
UI
$34.2B
$1.69M ﹤0.01%
16,995
-2,506
-13% -$248K
CDE icon
1749
Coeur Mining
CDE
$15.9B
$1.69M ﹤0.01%
377,562
+189,708
+101% +$897K
KAI icon
1750
Kadant
KAI
$3.97B
$1.69M ﹤0.01%
20,724
+4,519
+28% +$423K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.